?? Normal 0 7.8 ?? 0 2 P

D-19 here is currently the lowest in Europe." "We are ??sure that the future will bring even better epidemic control measur??es, that production will gradually restart, that people will return?? to work and that the economy will recover quickly along with effic??ient epidemic control," Peng said. Ambassador Chen said that the me??dals awarded to the Chinese doctors prove Serbia's care and respect??. "The epidemiological situation in Serbia is getting better but th??e battle is still ongoing. China is ready to continue its cooperati??on with Serbia and invest efforts into joint victory," she said. Ch??en said that the Chinese doctors have already spent a month in Serb??ia and provided valuable contributions to the fight against COVID-1??9. Three doctors will remain in Serbia to continue assisting their ??hosts in overcoming the pandemic, and the other three will return t??o China. Chen said that if needed, China is ready to send three mor??e experts to Serbia.We are all expecting a COVID-19 vaccine that could p??ossibly end the pandemic that has killed more than ??330,000 people. Now the first vaccine candidate fro??m China has finished its phase-1 trial on humans, a??nd the results have been put online for everyone to?? examine. The Lancet, a respected medical journal i??n the UK, published the results on Friday saying it?? is "safe" and "induces rapid immune response." The?? research injected the potential vaccine into 108 v??olunteers. They were divided into three groups, eac??h taking a different dose of the vaccine. The vacci??ne, classified as "recombinant adenovirus type-5 ve??ctored" (Ad5-nCoV), acts as a natural infection and?? is especially good at teaching the immune system h??ow to fight the virus. During the next 28 days, no ??serious reactions were found, meaning the vaccine s??eemed to be tolerable by humans. Also, antibodies a??gainst the SARS-CoV-2 started to surge two weeks af??ter the injection and reached its peak on day 28. T??he vaccine "warrants further investigation," the pa??per on The Lancet concluded. A phase-2 clinical tri??al has started with 508 volunteers involved. The tr??ial was conducted by a team led by Chen Wei, a biol??ogy professor from Academy of Military Medical Scie??nces and a member of the Chinese Academy of Enginee??ring. There are other two vaccines allowed for huma??n trials in China. They are ShaCoVacc and PiCoVacc.??BEIJING, March 31 (Xinhua) -- Fan Changlong, vice ??chairman of China's Central Military Commission, ??and Chang Wanquan, Chinese defense minister and s??tate councilor, on Friday met separately with Guy?? Parmelin, head of the Swiss Federal Department o??f Defense, Civil Protection and Sport. Fan Chang??long said China is willing to work with Switzerla??nd to implement consensus reached by leaders of t??he two countries, enhance strategic communication??, enrich military-to-military relations, and make?? positive contributions to the China-Switzerland ??innovative strategic partnership. Fan hailed the?? smooth development of military-to-military relat??ions in recent years and deepening of exchanges a??nd cooperation in areas such as the exchange of h??igh-level visits, persok

Parmelin said that ??Switzerland adheres to the one-China policy and i??s willing to advance pragmatic cooperation with C??hi6



na in all fields. Noting the good momentum of ??development in military-to-military relations, Ch??ang Wanquan said China i2


s willing to work with Sw??itzerland to deepen exchanges andN


pragmatic coope??ration between the two militaries. ParmeliU


n told?? Chang that Switzerland attaches much importance ??tS

Our Team


o developing ties with China6

Peter Parker

and is willing toT


w??ork together with China K

Michael Loe

to eleva7


te military-to-mi??litary re0

Mary Jane

lations to a new lU


evel. At least eight people K

Steven Carl

were repT

ortedly kilf







ng Ta9

Best Services

iwan's top military officialJ

  • ?? 9
  • 5
  • p


, after a he??lig


copter made an eD


mergency landingF


  • Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod possimus, omnis voluptas.

    John Frank

    C has, from 5

  • Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod possimus, omnis voluptas.

    Michael Doe

    the very beg1

  • Nam libero tempore, cum soluta nobis est eligendi optio cumque nihil impedit quo minus id quod possimus, omnis voluptas.

    Thomas Carl

    inning, statO

Trump acc7


Subscribe Here

ed clearly that people's life and heal0

    ?? n